Combination treatment extends survival in PH, pulmonary fibrosis

Combination treatment extends survival in PH, pulmonary fibrosis

Combining pulmonary vasodilators, medications that widen blood vessels, and antifibrotics, which slow the progression of scarring, may prolong survival and time without needing a transplant in people with both pulmonary hypertension (PH) and pulmonary fibrosis, a study suggested. “Antifibrotic and pulmonary vasodilator therapy could improve transplant-free survival in patients with pulmonary hypertension related to pulmonary fibrosis,” wrote thr…